| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 18 | +66.67% | -3.72% | +0.80% | -4.51% | -5.16% | — |
| 14d | 18 | +100.00% | -9.65% | +0.97% | -10.61% | -11.40% | — |
| 30d | 18 | +100.00% | -12.33% | +5.28% | -17.61% | -17.22% | — |
| 60d | 18 | +50.00% | -1.81% | +4.70% | -6.51% | -5.50% | — |
| 90d | 18 | +16.67% | +16.12% | +9.04% | +7.09% | +16.12% | — |
| 180d | 18 | +16.67% | +32.98% | +17.79% | +15.19% | +15.15% | — |
| 1y | 18 | +0.00% | +79.01% | +43.20% | +35.81% | +33.72% | — |
| 2y | 18 | +0.00% | +11.97% | +55.67% | -43.70% | -44.58% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 213 | $5.20 | $1.1K | 855,831 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 213 | $40.00 | $8.5K | 851,634 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 204 | $40.00 | $8.2K | 851,430 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 1,200 | $40.00 | $48.0K | 852,677 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 1,454 | $14.54 | $21.1K | 853,588 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 830 | $5.19 | $4.3K | 855,618 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 830 | $40.00 | $33.2K | 851,847 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 1,200 | — | — | 330,390 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 1,454 | — | — | 331,590 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 700 | $40.00 | $28.0K | 850,730 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 500 | $7.75 | $3.9K | 852,134 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 1,200 | $4.75 | $5.7K | 854,788 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 213 | — | — | 329,347 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 500 | $40.00 | $20.0K | 855,331 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 1,454 | $40.00 | $58.2K | 853,877 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 500 | — | — | 333,044 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 830 | — | — | 329,560 | Apr 28, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 200 | $40.00 | $8.0K | 851,734 | Apr 27, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 200 | — | — | 333,544 | Apr 27, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 200 | $5.19 | $1.0K | 851,934 | Apr 27, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 100 | $40.00 | $4.0K | 851,634 | Apr 27, 2020 | Apr 29, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 3,700 | $40.00 | $148.0K | 867,749 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 3,700 | — | — | 342,500 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 3,805 | $40.00 | $152.2K | 851,734 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 5,300 | — | — | 333,744 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 3,454 | $40.00 | $138.2K | 855,539 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 3,800 | $4.75 | $18.1K | 862,793 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 3,700 | $5.19 | $19.2K | 866,493 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 5,300 | $14.54 | $77.1K | 875,249 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 3,456 | $40.00 | $138.2K | 864,293 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 3,800 | — | — | 346,200 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 3,800 | $40.00 | $152.0K | 871,449 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 3,456 | — | — | 339,044 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE Chief Operating Officer | 3,456 | $5.20 | $18.0K | 869,949 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 5,300 | $40.00 | $212.0K | 858,993 | Apr 20, 2020 | Apr 22, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 22,466 | $60.37 | $1.36M | 860,293 | Jan 6, 2020 | Jan 8, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 11,847 | $59.57 | $705.7K | 882,759 | Jan 6, 2020 | Jan 8, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE Chief Operating Officer | 1,300 | $60.99 | $79.3K | 858,993 | Jan 6, 2020 | Jan 8, 2020 ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 894,606 | Jan 1, 2020 | Jan 3, 2020 ↗ |